Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $25.3 million.

  • Surgery Partners' Profit After Tax rose 17981.07% to $25.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$76.0 million, marking a year-over-year decrease of 21226.0%. This contributed to the annual value of -$168.1 million for FY2024, which is 22424.24% down from last year.
  • According to the latest figures from Q3 2025, Surgery Partners' Profit After Tax is $25.3 million, which was up 17981.07% from $44.9 million recorded in Q2 2025.
  • In the past 5 years, Surgery Partners' Profit After Tax registered a high of $57.7 million during Q2 2023, and its lowest value of -$108.5 million during Q4 2024.
  • Moreover, its 5-year median value for Profit After Tax was -$100000.0 (2021), whereas its average is $315789.5.
  • Its Profit After Tax has fluctuated over the past 5 years, first surged by 2340000.0% in 2022, then plummeted by 33233.4% in 2024.
  • Over the past 5 years, Surgery Partners' Profit After Tax (Quarter) stood at -$100000.0 in 2021, then surged by 23400.0% to $23.3 million in 2022, then surged by 100.43% to $46.7 million in 2023, then tumbled by 332.33% to -$108.5 million in 2024, then soared by 123.32% to $25.3 million in 2025.
  • Its Profit After Tax was $25.3 million in Q3 2025, compared to $44.9 million in Q2 2025 and -$37.7 million in Q1 2025.